Geneticimmunity

Geneticimmunity

Created using Figma
Created using Figma
We are a privately held clinical-stage biotechnology company focusing on the development and commercialization of a revolutionary new immune therapy technology platform for the treatment of chronic viral infections, cancer and allergy. Our Immune Therapies are designed to boost specific immune response in order to modify or control presently incurable diseases.
Sale
May 23, 2018
Jun 23, 2018
100% completed
Raised funds - no Data
past
Pre-sale
Feb 20, 2018
May 22, 2018
100% completed
Raised funds - no Data
past
Token Details
Ticker
DVT
Accepted Currencies
ETH
Additional Details
Categories
Platform, Health

About Geneticimmunity

Genetic Immunity is a US clinical-stage biotechnology company focusing on the discovery, development and commercialization of a new class of therapeutic vaccines ("Immune Therapies") for the treatment of chronic viral infections (HIV, HPV), cancer and allergies. Our Immune Therapies are designed to intensify and boost specific immune response to modify or control these presently incurable diseases. We believe our products will allow people to live better, healthier and longer lives.

Our proprietary immunotherapy platform is composed of an pDNA (plasmid DNA) expressing multiple disease specific antigens, a nanomedicine formulation encapsulating the pDNA and a topical administration device which targets the formulation transdermally to dendritic (Langerhans) cells of the skin. Our platform technologies support the rapid and cost-effective development of novel biologic products for several indications and provides tools for the selection of an optimal, patient specific treatment regimen.

Our Lead Product Candidate, a therapeutic vaccine for the treatment of HIV is effective in boosting immune response to kill HIV-infected cells. Our preclinical, Phase I, Phase I/II and Phase II trials have demonstrated HIV-specific T-cells immune response and boosting, and the killing of HIV-infected cells. DermaVir has an excellent safety profile. Our goal is to provide DermaVir as a co-treatment option to antiretroviral therapy (ART), and, upon the completion of an additional clinical trial, to demonstrate efficacy in ART resistant patients, thereby opening a safe, effective new treatment paradigm.

In addition to HIV we also work on an extensive pipeline including therapeutic treatments for cancer, the human papillomavirus, MAGE, allergies and more.

Please see our pipeline of virus-associated cancers and warts in discovery phase section of the website.

Features

Therapeutic Vaccine for treatment of HIV, referred to as “DermaVir”, is effective in boosting immune response which kills HIV-infected cells. Human clinical trials have demonstrated vaccine is capable of killing HIV-infected cells. DermaVir has a safety profile similar to vaccines used in healthy adults and children. DermaVir can also be a co-treatment option if administered with antiretroviral therapy.

Activity

Activity:
7
VERY LOW
Posts:
17
VERY LOW
Views:
237
VERY LOW
Followers:
271
VERY LOW
Tweets:
41
VERY LOW
30 Days Growth:
-25
Members:
69
VERY LOW
30 Days Growth:
6

Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Chief Executive Officer
unverified
Peter Boros
Chief Operations Officer
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Last News

N/A
5.0 20
ICO Profile Vision Activity Potential Product Team
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO